Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions

  • Manjunath P. Pai
  • Jennifer J. Kiser
  • Paul O. Gubbins
  • Keith A. Rodvold

Part of the Infectious Disease book series (ID)

Table of contents

  1. Front Matter
    Pages i-xvi
  2. Larry H. Danziger, Karolyn S. Horn
    Pages 1-56
  3. Manjunath P. Pai
    Pages 57-86
  4. David R. P. Guay
    Pages 87-138
  5. Mary A. Ullman, John C. Rotschafer
    Pages 139-166
  6. Gregory M. Susla
    Pages 167-219
  7. Rocsanna Namdar, Charles A. Peloquin
    Pages 221-253
  8. Parul Patel, Stan Louie
    Pages 255-295
  9. Christine E. MacBrayne, Jennifer J. Kiser
    Pages 357-380
  10. Douglas N. Fish
    Pages 381-424
  11. Jarrett R. Amsden, Paul O. Gubbins
    Pages 425-501
  12. Waheed A. Adedeji, Tunde Balogun, Fatai A. Fehintola, Gene D. Morse
    Pages 503-514
  13. Tony K. L. Kiang, Kyle John Wilby, Mary H. H. Ensom
    Pages 515-549
  14. Back Matter
    Pages 551-565

About this book


The 4th edition of Drug Interactions in Infectious Diseases is being split into two separate volumes – “Mechanisms and Models of Drug Interactions” and “Antimicrobial Drug Interactions”.

This volume, “Antimicrobial Drug Interactions,” delivers a quick clinical resource that distills relevant drug interactions by antimicrobial drug class. The book provides informative tables on specific drug-drug interactions that include the degree and severity of the expected interaction. A mechanistic basis for drug-drug interactions is also provided to link observed interactions to pharmacologic characteristics of key drug classes. This complete resource is organized by major antibacterial, antimycobacterial, antiviral, antifungal, antimalarial, and antiprotozoal class. In line with current innovations in antimicrobial drug development, a distinct chapter on the pharmacologic management of drug interactions in hepatitis B virus (HBV) and hepatitis C virus (HCV)-related infections is included.  Two new chapters are dedicated to the management of human immunodeficiency virus (HIV) drug-drug interactions given the breadth of antiretroviral class-specific effects. This comprehensive review of known drug interactions and strategies to manage them is an invaluable resource to all health care practitioners.


infectious disease drug interactions HIV HCV HBV antimicrobials

Editors and affiliations

  • Manjunath P. Pai
    • 1
  • Jennifer J. Kiser
    • 2
  • Paul O. Gubbins
    • 3
  • Keith A. Rodvold
    • 4
  1. 1.College of PharmacyUniversity of MichiganAnn ArborUSA
  2. 2.Department of Pharmaceutical Sciences, Skagg School of Pharmacy and Pharmaceutical SciencesUniversity of ColoradoAuroraUSA
  3. 3.Division of Pharmacy Practice and AdministrationUMKC School of Pharmacy at MSUSpringfieldUSA
  4. 4.College of Pharmacy and MedicineUniversity of Illinois at ChicagoChicagoUSA

Bibliographic information

  • DOI
  • Copyright Information Springer International Publishing AG, part of Springer Nature 2018
  • Publisher Name Humana Press, Cham
  • eBook Packages Medicine Medicine (R0)
  • Print ISBN 978-3-319-72415-7
  • Online ISBN 978-3-319-72416-4
  • Buy this book on publisher's site